MTARC1 and Hepatic fibrosis: The temporal effect of loss of mARC1 is most evident in our siRNA therapeutic intervention model where intervention with knockdown of mARC1 at week 16 improved liver fibrosis but intervention at week 24 did not (Figure 6 and Supplemental Figure S6, http://links.lww.com/HC9/B878).